185 related articles for article (PubMed ID: 9763219)
1. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
Peffley DM; Gayen AK; Morand OH
Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
[TBL] [Abstract][Full Text] [Related]
2. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin.
Morand OH; Aebi JD; Dehmlow H; Ji YH; Gains N; Lengsfeld H; Himber J
J Lipid Res; 1997 Feb; 38(2):373-90. PubMed ID: 9162756
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
Cenedella RJ
Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
[TBL] [Abstract][Full Text] [Related]
4. Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.
Chuang JC; Valasek MA; Lopez AM; Posey KS; Repa JJ; Turley SD
Biochem Pharmacol; 2014 Apr; 88(3):351-63. PubMed ID: 24486573
[TBL] [Abstract][Full Text] [Related]
5. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes.
Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA
Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959
[TBL] [Abstract][Full Text] [Related]
6. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Telford DE; Lipson SM; Barrett PH; Sutherland BG; Edwards JY; Aebi JD; Dehmlow H; Morand OH; Huff MW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2608-14. PubMed ID: 16210564
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells.
Mark M; Muller P; Maier R; Eisele B
J Lipid Res; 1996 Jan; 37(1):148-58. PubMed ID: 8820110
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol.
Leonard DA; Kotarski MA; Tessiatore JE; Favata MF; Trzaskos JM
Arch Biochem Biophys; 1994 Apr; 310(1):152-7. PubMed ID: 8161198
[TBL] [Abstract][Full Text] [Related]
9. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin on lipid metabolism in normolipidemic and hereditary hyperlipidemic, non-laying hens.
Elkin RG; Zhong Y; Donkin SS; Hengstschläger-Ottnad E; Schneider WJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Mar; 143(3):319-29. PubMed ID: 16413806
[TBL] [Abstract][Full Text] [Related]
11. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Anderson JA; Leonard DA; Cusack KP; Frye LL
Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
[TBL] [Abstract][Full Text] [Related]
12. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
13. An oxysterol-derived positive signal for 3-hydroxy- 3-methylglutaryl-CoA reductase degradation in yeast.
Gardner RG; Shan H; Matsuda SP; Hampton RY
J Biol Chem; 2001 Mar; 276(12):8681-94. PubMed ID: 11134013
[TBL] [Abstract][Full Text] [Related]
14. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
Llorente-Cortés V; Martínez-González J; Badimon L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneoplastic liver nodules.
Pascale RM; Simile MM; De Miglio MR; Nufris A; Seddaiu MA; Muroni MR; Danni O; Rao KN; Feo F
Carcinogenesis; 1995 Jul; 16(7):1537-42. PubMed ID: 7614686
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo.
Eisele B; Budzinski R; Müller P; Maier R; Mark M
J Lipid Res; 1997 Mar; 38(3):564-75. PubMed ID: 9101437
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control.
Peffley DM
Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367
[TBL] [Abstract][Full Text] [Related]
18. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Mafuvadze B; Liang Y; Hyder SM
Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
[TBL] [Abstract][Full Text] [Related]
20. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation.
Martínez-González J; Raposo B; Rodríguez C; Badimon L
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):804-9. PubMed ID: 11348878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
